兰卫医学：公司2026年的具体业务进展与规划敬请关注公司2025年年度报告

Core Viewpoint - Lanwei Medical indicated that specific business progress and plans for 2026 will be detailed in the 2025 annual report, highlighting the company's commitment to transparency and investor communication [1] Group 1 - The company's stock price is influenced by multiple factors, and it aims to maintain strong production and operations while actively rewarding investors [1] - Lanwei Medical will strictly adhere to relevant laws and regulations regarding information disclosure, ensuring timely and accurate communication with investors [1] - The company encourages investors to make rational investment decisions and to be cautious [1]